| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 02/16/2006 | WO2005058798A3 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same |
| 02/16/2006 | US20060035925 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/16/2006 | US20060035865 Lipid-rich plaque regressing agents |
| 02/16/2006 | DE102004032440A1 Use of 6,7,8-trihydroxy-2H-1-benzopyran-2-ones to treat or prevent diseases involving oxidative stress and/or inflammatory reactions |
| 02/16/2006 | CA2575582A1 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents, etc. |
| 02/16/2006 | CA2574597A1 Alpha-ketoglutarates and their use as therapeutic agents |
| 02/15/2006 | EP1626041A2 New materials useful as electolytic solutes |
| 02/15/2006 | EP1625112A1 Novel compounds for treatment of obesity |
| 02/15/2006 | EP0994871B1 Novel substituted naphthopyrans |
| 02/15/2006 | CN1733767A Cyclohexanone analog saturated triring(bridge)compound and its preparation method and uses |
| 02/15/2006 | CN1733765A Purple bergenia element pentaacetylate and its uses |
| 02/15/2006 | CN1733755A High purity delta-alpha-tocopherol succinic acid monoester preparation method |
| 02/15/2006 | CN1733754A Method for extracting persimmon polyphenol from persimmon |
| 02/15/2006 | CN1733753A Epigallocatechin gallate monomer purification method |
| 02/15/2006 | CN1733752A Emblic leafflower fruit extract possessing anticancer, antibiotic actions and its manufacturing method of traditional Chinese medicine formulation |
| 02/15/2006 | CN1733751A Novel method for synthesizing daphnetin |
| 02/15/2006 | CN1733693A Compound essence of Dothiorella and its preparation method and uses |
| 02/15/2006 | CN1242067C Method for preparing intermidiate of VE |
| 02/15/2006 | CN1241927C Efficient method for refining tetrodotoxin by liquid-phase method |
| 02/15/2006 | CN1241926C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 02/15/2006 | CN1241922C Process for producing soybean isoflavone by waste water of bean products factory |
| 02/15/2006 | CN1241921C Fluoro isoflavone containing derivative, monufacturing method and its use |
| 02/15/2006 | CN1241920C Preparation process for dragon's blood total flavonoids |
| 02/15/2006 | CN1241574C Medicine for relieving spasm and pain and preparation process thereof |
| 02/14/2006 | US6998493 Colorant compounds |
| 02/14/2006 | US6998417 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents |
| 02/14/2006 | CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
| 02/09/2006 | WO2006012965A1 Difluorosubstituted heterocyclic compounds and the use thereof in the form of components in liquid crystalline media |
| 02/09/2006 | US20060030673 Oxygen-containing heterocyclic fused naphthopyrans |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030054 6-Hydroxy--2-xanthenone derivatives 9-substituted by a phenyl ring with 1 or 2 substituents for trapping protons, metal ions (Na, Mg, Ca, Zn) or active oxygen species, and which may combine to form a fused ring such as anthracene or benzo-15-crown-5; after trapping compound formed is highly fluorescent |
| 02/09/2006 | DE102004063910A1 Verwendung von trisubstituierten Benzopyranonen Use of trisubstituted Benzopyranonen |
| 02/08/2006 | EP1623712A2 Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues |
| 02/08/2006 | EP1623707A1 Medicinal composition for treating sudden deafness |
| 02/08/2006 | EP1623024A2 Crystals of cytochrome p450 2c9, structures thereof and their use |
| 02/08/2006 | EP1622898A1 Processes for making thiazolidinedione derivatives and compounds thereof |
| 02/08/2006 | EP1622889A2 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives |
| 02/08/2006 | EP1622888A1 Benzo-, naphtho- and phenanthrochromenes substituted with an arylamine group with photochromic properties |
| 02/08/2006 | EP1622887A2 Process for the manufacture of tocyl and tocopheryl acylates |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1730479A Aloe dihydro-coumarin and its separation method and uses |
| 02/08/2006 | CN1240702C Process for extracting tetrodosin with high output rate |
| 02/08/2006 | CN1240698C Isoflavone compound preparing method |
| 02/08/2006 | CN1240697C Technical method for extracting oridinin from rabdosia rubescens |
| 02/08/2006 | CN1240679C 2- and 2,5-substituted phenylketoenols |
| 02/08/2006 | CN1240388C Selective estrogen receptor modulator in combination with dehydroepiandrosterone or its derivative |
| 02/07/2006 | US6995187 Peripheral cannabinoid receptor (CB2) selective ligands |
| 02/07/2006 | CA2403584C Process for obtaining solid soy isoflavone-containing products |
| 02/07/2006 | CA2236382C Process for the production of 2h-1-benzopyrans |
| 02/07/2006 | CA2216288C Uracilic hydroquinone derivatives as type iv allergy inhibitors |
| 02/02/2006 | WO2006011669A1 Novel cinnamic acid related compounds |
| 02/02/2006 | WO2006011047A1 Enantioselective method for separing substituted 2-trifluoromethyl-2h-chromene-3-carboxylic acid derivatives |
| 02/02/2006 | WO2005047245A3 Fluorescence assays with improved blocking groups |
| 02/02/2006 | US20060025471 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
| 02/02/2006 | US20060024704 Detection of markers in nascent proteins |
| 02/02/2006 | US20060024396 Method of treating diabetes and obesity using carbohydrate absorption inhibitors |
| 02/02/2006 | US20060022176 Photochromic materials |
| 02/02/2006 | DE102004034683A1 Verfahren zur Isolierung von α-Mangostin A method for isolating α-mangostin |
| 02/02/2006 | CA2574363A1 Enantioselective method for separating sustituted 2-trifluoromethyl-2h-chromene-3-carboxylic acid derivatives |
| 02/02/2006 | CA2573547A1 Photoracemization of 2-trifluoromethyl-2h-chromene-3-carboxylic acid derivatives |
| 02/01/2006 | EP1620421A2 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
| 02/01/2006 | EP1620401A2 Phenyl substituted cyclic derivatives |
| 02/01/2006 | EP1620093A2 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives |
| 02/01/2006 | EP1620089A1 Therapeutic and prophylactic compositions and uses therefor |
| 02/01/2006 | EP1620086A1 Compounds that modulate ppar activity and methods of preparation |
| 02/01/2006 | EP0901996B1 Process for producing optically active amines |
| 02/01/2006 | CN1729266A Photochromic compositions and light transmissible articles |
| 02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/01/2006 | CN1727339A Tricyclic compounds, their production and use |
| 02/01/2006 | CN1726956A Extract product of general flavone of kudzuvine root, preparation method and application |
| 02/01/2006 | CN1239494C Chrysin-6-sulfonic tetranuclear calcium coordination compound, and its preparing method and use of photoluminescence property |
| 01/31/2006 | US6991914 Hydrolysis of 3,7-dialkanoyloxyphenoxazine derivative; measuring fluorescence |
| 01/31/2006 | US6991776 Halogenated xanthene or halogenated xanthene derivative; cancer treatment |
| 01/31/2006 | CA2347599C Process for the preparation of pyrimidine compounds |
| 01/31/2006 | CA2327498C Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 01/31/2006 | CA2152506C Use of prodelphinidines for treating osteoarthritis |
| 01/26/2006 | WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | WO2006010094A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
| 01/26/2006 | WO2006008030A1 Method for the isolation of alpha-mangostin |
| 01/26/2006 | WO2006007734A1 Method for obtaining pure tetrahydrocannabinol |
| 01/26/2006 | US20060020139 Acid-catalyzed reaction of trimethylhydroquinone with isophytol or phytol in the presence of methane trisulphonate as the catalyst in an organic solvent, the amount of the methane trisulphonate catalyst |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020023 Racemization method |
| 01/26/2006 | US20060020022 Enantioselective separation method |
| 01/26/2006 | US20060020008 Compounds, compositions and methods |
| 01/26/2006 | US20060019947 Therapeutic chromone compounds |
| 01/26/2006 | US20060019371 Macrolide analogs |
| 01/26/2006 | US20060016683 Photoracamization method |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/26/2006 | CA2573859A1 Method for obtaining pure tetrahydrocannabinol |
| 01/26/2006 | CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | CA2572775A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
| 01/25/2006 | EP1618102A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 01/25/2006 | EP1618101A2 Benzochromene derivatives |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 01/25/2006 | CN1724535A Production method of 9-nitro camptothecin |
| 01/25/2006 | CN1724532A Colorant compounds |